LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 21.17 | 770.25 | 1025 | 2008 | 0.5104 | 0.2296 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 21.17 | 770.25 | 1034 | 2008 | 0.5148 | 0.2374 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 23.39 | 770.25 | 1020 | 2244 | 0.4544 | 0.1996 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 23.39 | 770.25 | 1003 | 2244 | 0.4469 | 0.1866 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 25.62 | 770.25 | 1015 | 2514 | 0.4036 | 0.1754 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 25.62 | 770.25 | 1008 | 2514 | 0.4008 | 0.1707 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 27.84 | 770.25 | 1014 | 2833 | 0.3578 | 0.1575 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 27.84 | 770.25 | 1004 | 2833 | 0.3543 | 0.1515 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 30.06 | 770.25 | 1027 | 3106 | 0.3306 | 0.1537 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 30.06 | 770.25 | 989 | 3106 | 0.3184 | 0.1323 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 32.28 | 770.25 | 992 | 3392 | 0.2924 | 0.1256 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 32.28 | 770.25 | 1004 | 3392 | 0.2959 | 0.1319 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 34.50 | 770.25 | 1016 | 3712 | 0.2737 | 0.1298 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 34.50 | 770.25 | 985 | 3712 | 0.2654 | 0.1145 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 36.73 | 770.25 | 1007 | 4086 | 0.2464 | 0.1178 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 36.73 | 770.25 | 971 | 4086 | 0.2376 | 0.1010 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 38.95 | 770.25 | 994 | 4543 | 0.2188 | 0.1047 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 38.95 | 770.25 | 962 | 4543 | 0.2117 | 0.0907 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 41.17 | 770.25 | 988 | 5010 | 0.1972 | 0.0965 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 41.17 | 770.25 | 970 | 5010 | 0.1936 | 0.0891 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 43.39 | 770.25 | 1000 | 5404 | 0.1850 | 0.0973 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 43.39 | 770.25 | 953 | 5404 | 0.1763 | 0.0787 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 45.61 | 770.25 | 981 | 5813 | 0.1688 | 0.0865 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 45.61 | 770.25 | 927 | 5813 | 0.1595 | 0.0656 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 47.83 | 770.25 | 960 | 6223 | 0.1543 | 0.0758 | MN20160304_L02 | F05 |